European Commission issues GDP norms, Indian pharma conform to new rules

European Commission has issued a guidance on Good Distribution Practice (GDP) of medicinal products for human use. Indian pharma companies see the new norms would transform the pharma marketing in the region.

“We will now need to ensure that all drugs to be exported to the European Union will need to adhere to the new norms of European Commission. The fact is that most of us are on course,” said pharma companies like Biocon, Micro Labs and Dr. Reddy’s have already ample trade presence in the region.

Read more at: pharmabiz.com